For you
For investors and corporate VC
UAX is an early-stage advanced-materials company with genuine dual-use exposure. That combination makes ownership, IP title and control-list classification the first questions worth asking — so they are the first questions this page answers.
The public-safe offer
The unclassified investor brief is a short document covering the legal entity, the governance and ring-fencing options, how background and foreground intellectual property is treated, and the sequence a diligence process would follow. It contains no performance data, no valuation, no projections and no return figures — because none of those exist in a publishable form.
Download the investor brief (PDF)
Institutional webmail often ignores mailto: links. These two buttons exist so a corporate or government mailbox is never a dead end.
We aim to acknowledge enquiries within three (3) Türkiye business days. Acknowledgement confirms receipt only; it grants no access and creates no relationship.
Is this actually relevant to you?
- You invest in deep tech at a stage where the science, not the revenue, is the asset — and you are comfortable with a company that publishes no test results.
- Dual-use exposure is something your mandate can accommodate, including the possibility that a transfer or an ownership change becomes a notifiable event under Turkish law.
- You would want the ring-fenced civil route as a real option, rather than exposure to the defence-adjacent line as a package deal.
What you can check today, without asking us
What stays gated, and why
Registration identifiers, capital structure, named leadership credentials and the exact facility address are not published. That is a disclosure policy, not an absence of record: each field exists and is provided at the identity-verification and NDA stage. Nothing about the investment case depends on those fields being public.
Your next step
Ask for the brief first. If it holds up, the natural second step is a governance and IP briefing — still before any technical material, and still without an NDA. Nothing on this page or in the brief is an offer, a solicitation or investment advice.
This site is not an offer, solicitation, or recommendation to buy or sell any security or to make any investment, and it is not investment, legal, tax, or export-control advice. Nothing here guarantees any outcome or return. Regulatory references are general context from public sources, may be incomplete or change, and require confirmation by qualified Japanese and Turkish counsel. Engagement is limited to qualified, professional, or institutional counterparties through the controlled pathway.